Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells

Transfusion
Beatrice GrossjohannHartmut Kroll

Abstract

Ceftriaxone, a third-generation cephalosporin, has been reported to occasionally cause fatal drug-induced immune hemolytic anemia (DIHA). A clinical and serologic analysis of the first two patients with severe drug-induced thrombocytopenia (DITP) due to ceftriaxone and one patient with fatal DIHA is reported. Sera were assessed by the IAT, EIA, glycoprotein (GP)-specific immunoassay, flow cytometry, and immunoprecipitation using transfectants expressing GPIIb/IIIa and GPIb/IX and with different cephalosporins. Sera from Patients 1 and 2 reacted strongly with PLTs in the presence of the drug, but not with RBCs. The binding sites of the drug-dependent antibodies (DDAbs) could be localized to GPIIb/IIIa and GPIb/IX, respectively. Inhibition studies indicated that DDAbs recognized epitopes residing on the GPIIb/IIIa complex and on the GPIX subunit, respectively. No cross-reactivity was observed with other cephalosporin derivatives. Serum 3 showed strong agglutination with RBCs of Rh(null) phenotype in the presence of ex-vivo metabolites of ceftriaxone, but no cross-reactivity with PLTs. The first two cases of severe DITP and a third patient with DIHA are reported. DDAbs from all patients showed individual reaction patterns and clea...Continue Reading

References

Jun 1, 1979·Molecular Immunology·T J Kunicki, R H Aster
Sep 1, 1992·Transfusion Medicine·V Kiefel
Jul 1, 1992·Transfusion·A SalamaC Mueller-Eckhardt
Feb 1, 1991·DICP : the Annals of Pharmacotherapy·R L Hull, D Brandon
Dec 1, 1988·British Journal of Haematology·D J ChristieC D Swinehart
Jan 1, 1994·Scandinavian Journal of Infectious Diseases·T TantawichienD Swasdikul
Dec 29, 1998·Annals of Internal Medicine·J N GeorgeT Vondracek
Nov 11, 1999·British Journal of Haematology·O MeyerA Salama
Apr 18, 2003·American Journal of Hematology·O S AljitawiR H Aster

❮ Previous
Next ❯

Citations

Oct 12, 2011·International Journal of Clinical Pharmacy·Phin Phin LimNoorizan Abdul Aziz
Sep 11, 2010·Expert Review of Clinical Immunology·Esther Morena RodillaFélix Lorente Toledano
Sep 2, 2008·Expert Opinion on Drug Safety·Scott V MonteJoseph A Paladino
Apr 21, 2010·Best Practice & Research. Clinical Anaesthesiology·Bruce D Spiess
Mar 4, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yuji HiraiKyoichi Totsuka
Apr 9, 2005·British Journal of Haematology·Stephen F GarnerWillem H Ouwehand
Apr 7, 2009·Journal of Thrombosis and Haemostasis : JTH·R H AsterD W Bougie
Jun 21, 2008·Transfusion·Marina MartinengoGiorgio Reali
Dec 26, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nisha Chand, Arun J Sanyal
Nov 6, 2012·Journal of Thrombosis and Haemostasis : JTH·D M ArnoldJ G Kelton
Jan 22, 2015·Journal of Thrombosis and Haemostasis : JTH·D M ArnoldUNKNOWN Subcommittee on Platelet Immunology
Dec 6, 2014·Hospital Pharmacy·Hanine MansourPaul Khoueiry
Aug 29, 2014·The Annals of Pharmacotherapy·Gal NeumanShinya Ito
Sep 16, 2008·Platelets·Barton Kenney, Christopher A Tormey
Feb 20, 2007·Clinical Orthopaedics and Related Research·Douglas L CerynikNirav H Amin
Jul 17, 2020·Journal of Clinical Medicine·Caroline VayneYves Gruel
Feb 7, 2009·Archives of Pathology & Laboratory Medicine·Barton Kenney, Gary Stack
Sep 8, 2021·BMJ Case Reports·Aishwarya SharmaAmit Kaushal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.